GO
Loading...

Biogen Idec Inc

More

  • Pipeline Of Profits! Monday, 28 Jul 2008 | 4:00 PM ET

    Pete Najarian reveals 3 biotechs he feels provide the most bang for the buck?

  • The Latest Picks That Paid – Friday July 25th Friday, 25 Jul 2008 | 7:18 PM ET
    Quicker Ticker

    Our traders are good - but you knew that! Check out their latest picks that paid.

  • Pops & Drops: AIG, Hasbro... Monday, 21 Jul 2008 | 6:44 PM ET

    Following are the day’s biggest winners and losers. Find out why shares of AIG and Biogen popped while Hasbro and CME Group dropped.

  • The buyout offer from Swiss drug giant Roche has shares of DNA trading at their highest level in about two-and-a-half years and according to CNBC stock-stat maven, Robert Hum, if they close up at least 8.88% it'll be their biggest one-day percentage gain since April 15, 2005.

  • Bear Market Band-Aid Tuesday, 15 Jul 2008 | 6:26 PM ET

    You’ve gotta’ love modern medicine. Not only does it cure stomach upset now it may be the best remedy for what ails your portfolio.

  • Oil Drops, Stocks Pop Tuesday, 8 Jul 2008 | 5:51 PM ET

    The Dow rose Tuesday in another turbulent session after a pullback in oil prices eased worries about consumer and business spending. What's the "Word on the Street?"

  • Pfizer and the State of Statins Monday, 23 Jun 2008 | 11:15 AM ET

    As much as I tried to disconnect during my vacation last week, I couldn't escape the ubiquitous presence of pharmaceuticals in our everyday lives...

  • Icahn Finally Adopts His Own Web Strategy Thursday, 19 Jun 2008 | 3:59 PM ET
    Carl Icahn

    Corporate raider Carl Icahn has had much to say about Yahoo's internal machinations and its refusal to submit to the hostile overtures of Microsoft. He's had much to say about the company's planned partnership with Google, which surprisingly, seemed a little more positive than many experts had anticipated.

  • High oil prices and a wary skittishness among traders keeps the pressure on stocks going into Thursday's session. Weekly jobless data, reported at 8:30am ET, is the big number ahead of Thursday's bell. The Philadelphia Fed survey and leading indicators are released at 10am.

  • Market Insider: Thursday Look Ahead Wednesday, 18 Jun 2008 | 8:02 PM ET

    High oil prices and a wary skittishness among traders keeps the pressure on stocks going into Thursday's session.

  • Now we bring you even more Fast ways to trade tomorrow's market moving events. Also Jon Najarian's options action trade!

  • Shareholder Discontent at Biogen, Yahoo, CSX Tuesday, 10 Jun 2008 | 12:44 PM ET

    ISS recommends a vote against dissident slate and looks ahead to CSX' shareholder meeting.

  • Biotech’s Biggest Weekend Wednesday, 28 May 2008 | 6:27 PM ET

    With the ASCO conference beginning Friday new cancer drugs are likely to grab headlines. How should you trade ahead of biotech’s biggest weekend?

  • Icahn To Go Behind-The-Scenes At Biogen Idec Wednesday, 21 May 2008 | 4:41 PM ET

    So, Carl Icahn is grabbing headlines this week over his new battle with Yahoo and how Boone Pickens is backing him up now, too. But Icahn has his finger in a lot of pies. He's still in a proxy fight with Biogen Idec where he's trying to get his people on the Board at the upcoming shareholder meeting on June 19th.

  • Your First Move For Wednesday Apr. 30th Tuesday, 29 Apr 2008 | 6:47 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Tech Gains Boost Nasdaq; Airlines Rise Tuesday, 29 Apr 2008 | 5:04 PM ET

    Stocks closed mixed in thin trading Tuesday as the tide turned in technology's favor. Airline stocks rose as oil prices receded. Merck skidded after an FDA rejection.

  • Stocks Turn Higher; Airlines Rise Tuesday, 29 Apr 2008 | 2:55 PM ET

    Stocks pushed higher Tuesday despite concerns about interest rates ahead of the Federal Reserve's decision. Merck skidded after an FDA rejection. Airline stocks rose as oil prices receded.

  • Merck Drags on Dow; Airline Stocks Rise Tuesday, 29 Apr 2008 | 2:44 PM ET

    Stocks declined Tuesday amid concerns about interest rates and a slide in consumer confidence. Merck dragged on the Dow industrials after the FDA rejected a key cholesterol drug.

  • Genentech, Biogen Idec Shares Hit by Study Results Tuesday, 29 Apr 2008 | 12:07 PM ET

    Genentech and Biogen Idec said a key study of Rituxan did not meet its main goal of a response in patients with systemic lupus erythematosus, commonly called lupus.

  • Merck "Adapts" To Tredaptive Setback Tuesday, 29 Apr 2008 | 11:37 AM ET

    Investors are finding no solace in Merck's reaffirmation that it'll still hit its earnings numbers this year. Instead they're punishing the stock after the company announced what everyone is calling a surprise and a significant setback.